| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2007. Published by Oxford University Press.
CORRESPONDENCE |
Response: Re: Commonly Studied Single-Nucleotide Polymorphisms and Breast Cancer: Results From the Breast Cancer Association Consortium
On behalf of the Breast Cancer Association Consortium
Correspondence to: Paul Pharoah, MD, PhD, Strangeways Research Laboratory, Department of Oncology, Worts Causeway, University of Cambridge, Cambridge CB1 8RN, UK (e-mail: paul1@srl.cam.ac.uk).
| The first 10% of the full text of this article appears below. |
We thank the correspondents for their comments. Ambrosone et al. suggest that our interpretation of our results represents a growing divergence in perspective between investigators with a statistical genetic viewpoint and those with a molecular epidemiology viewpoint. We do not subscribe to this view. The Breast Cancer Association Consortium (BCAC) represents a wide spectrum of researchers, from statistical geneticists to clinical oncologists, and includes investigators who regard themselves as molecular epidemiologists. Moreover, in several respects, our interpretation
Related Correspondence
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2007 99: 487.
This article has been cited by other articles:
![]() |
P. A. Thompson Counterpoint: Genetic Risk Feedback for Common Disease Time to Test the Waters Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1727 - 1729. [Full Text] [PDF] |
||||
